Doxorubicin hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
45963-733 -
Package NDC
45963-733-55 -
Package NDC
45963-733-57 -
Package NDC
45963-733-60 -
Package NDC
45963-733-68 -
Application number
ANDA203622 -
SPL ID
2ad7c99b-8cea-4e22-826f-9e49c90605b6 -
SPL set ID
33ddfdb1-b4bc-464d-a186-49c4b156279f -
UNII
82F2G7BL4E -
RxCUI
1191138 -
RxCUI
1790097 -
RxCUI
1790099 -
RxCUI
1790100
What the source publishes
- Labeler
- Actavis Pharma, Inc.
- Active ingredients
- Doxorubicin hydrochloride
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Doxorubicin hydrochloride",
"splId": "2ad7c99b-8cea-4e22-826f-9e49c90605b6",
"labels": [
{
"setId": "33ddfdb1-b4bc-464d-a186-49c4b156279f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33ddfdb1-b4bc-464d-a186-49c4b156279f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33ddfdb1-b4bc-464d-a186-49c4b156279f"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Actavis Pharma, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (45963-733-55) / 5 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "45963-733-55",
"identifierStatus": "well-formed",
"marketing_start_date": "20141101"
},
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (45963-733-57) / 10 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "45963-733-57",
"identifierStatus": "well-formed",
"marketing_start_date": "20141101"
},
{
"sample": false,
"description": "1 VIAL, MULTI-DOSE in 1 CARTON (45963-733-60) / 100 mL in 1 VIAL, MULTI-DOSE",
"package_ndc": "45963-733-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20141101"
},
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (45963-733-68) / 25 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "45963-733-68",
"identifierStatus": "well-formed",
"marketing_start_date": "20141101"
}
],
"productId": "45963-733_2ad7c99b-8cea-4e22-826f-9e49c90605b6",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "45963-733",
"deaSchedule": null,
"genericName": "Doxorubicin hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DOXORUBICIN HYDROCHLORIDE",
"strength": "2 mg/mL"
}
],
"applicationNumber": "ANDA203622",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20141101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"82F2G7BL4E"
],
"rxcui": [
"1191138",
"1790097",
"1790099",
"1790100"
],
"spl_set_id": [
"33ddfdb1-b4bc-464d-a186-49c4b156279f"
],
"manufacturer_name": [
"Actavis Pharma, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:45963-733_2ad7c99b-8cea-4e22-826f-9e49c90605b6"